Oregon Health and Science University-Knight Cancer Institute

Portland, Oregon 97329

3 studies enrolling now · 7 studies all time

What they study most

ALK-Positive Large B-Cell Lymphoma, AML, Burkitt Lymphoma, Central Nervous System Lymphoma, Chronic Lymphocytic Leukemia, DLBCL, DLBCL Germinal Center B-Cell Type, Duodenal-Type Follicular Lymphoma, EBV-Positive DLBCL, Nos, Follicular Lymphoma, Gastrointestinal Stromal Tumor, HHV8-Positive DLBCL, Nos

Studies at this site

• Lentiviral Gene Therapy (Zamtocabtagene Autoleucel) LTFU — Recruiting now
• DALY II USA/ MB-CART2019.1 for DLBCL — Recruiting now
• Study of SGR-1505 in Mature B-Cell Neoplasms — Recruiting now
• Phase 1-2 Study of Low Dose ASTX727 (ASTX727 LD) in Lower Risk MDS — Completed
• (QuANTUM-R): An Open-label Study of Quizartinib Monotherapy vs. Salvage Chemotherapy in Acute Myeloid Leukemia (AML) Subjects Who Are FLT3-ITD Positive — Completed
• A Study Evaluating STA-9090 in Patients With Metastatic and/or Unresectable Gastrointestinal Stromal Tumor (GIST) — Completed
• A Study of Alvimopan for the Management of Postoperative Ileus in Participants Undergoing Radical Cystectomy — Completed